Skip to content

Application of automatic nucleic acid detection technology

Application of automatic nucleic acid detection technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056755
Enrollment
Unknown
Registered
2022-02-13
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathogen detection

Interventions

Gold Standard:The existing reagents and instruments in the laboratory for detecting respiratory and reproductive tract infections (including those caused by respiratory syncytial virus, parainfluenza
Index test:respiratory syncytial virus, parainfluenza virus, Ureaplasma urealyticum, Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus, Mycoplasma genitalium and other pathogens

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients in Shenzhen Second People's hospital have symptoms of acute respiratory tract infection or reproductive tract infection. The remaining samples of respiratory virus nucleic acid six joint test and clinical detection related to reproductive tract pathogens were collected.

Exclusion criteria

Exclusion criteria: Samples with a volume less than 500 µ L are regarded as invalid samples; The samples due to instrument or human factors cannot be re inspected shall be removed.

Design outcomes

Primary

MeasureTime frame
ASV?PIV?NG?CT?UU?MG?HSV;

Countries

China

Contacts

Public ContactGu Dayong
wanhood@163.com13602601597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026